Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Schenkein David P
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   174,790    

Indirect Shares

  417,826      
Direct Value   $6,584,566    

Indirect Value

  $17,850,076      
Total Shares   592,616      
Total Value   $24,434,642      


Agios Pharmaceuticals Inc
 $5,849,079 Foundation Medicine, Inc.
 $0 Bluebird Bio, Inc.
 $6,183 Denali Therapeutics Inc.
 $446,472 Regeneron Pharmaceuticals Inc
 $282,832 Agios Pharmaceuticals Inc
 $5,849,079 Foundation Medicine, Inc.
 $0 Bluebird Bio, Inc.
 $6,183 Denali Therapeutics Inc.
 $446,472 Regeneron Pharmaceuticals Inc
 $282,832
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    3    

     Stock price went up :

    0   
    3    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   3.0   
     Percentage Gain/Loss :
     0.0%
 127.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Agios Pharmaceuticals Inc AGIO Director 2024-02-27 122,854 2024-02-27 349,854    Premium*  
            Foundation Medicine, Inc. FMI Director 2016-06-16 23,326 2016-06-16 10,508    Premium*  
            Bluebird Bio, Inc. BLUE 2020-06-18 6,832 2014-12-19 0    Premium*  
            Denali Therapeutics Inc. DNLI Director 2024-05-31 21,496 2024-05-31 57,464    Premium*  
            Regeneron Pharmaceuticals Inc REGN Director 2024-01-02 282 2023-09-08 0    Premium*  
* Premium Members only  

Records found :    154         Free Registration Required For Full Results.    Limit: 25

Download
  Page 7 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2024-02-26 4 S $33.19 $677,441 D/D (20,411) 122,854 0 %
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2024-02-27 4 OE $31.64 $2,193,570 D/D 69,329 180,325 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2024-02-27 4 S $33.60 $2,403,592 D/D (69,329) 122,854 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2024-05-31 4 A $0.00 $0 D/D 5,967 21,496 0 -

  154  Records found
  1   2   3   4   5   6   7     
  Page 7 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed